Michael S. Poirier - Jul 11, 2022 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Role
Chairman and CEO, Director
Signature
/s/ Michael S. Poirier
Stock symbol
QLGN
Transactions as of
Jul 11, 2022
Transactions value $
$0
Form type
4
Date filed
8/4/2022, 04:16 PM
Previous filing
Jun 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QLGN Stock Option (Right to Buy) Award $0 +375K $0.00 375K Jul 11, 2022 Common Stock 375K $0.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the stock option vest over three years in equal annual installments from the date of grant.